Business
Rocket Doctor AI Inc Announces Closing of C$4.23m Over-Subscribed Non-Brokered Private Placement of Special Warrants and Units
Vancouver, British Columbia, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated 25th July, 2025, it has closed its non-brokered private placement of 3,677,400 special warrants of the Company (each, a “Special Warrant”) at a price of $0.50 per Special Warrant, for aggregate gross proceeds of C$1,838,700 and 4,792,000 units of the Company (each, a “
About this update from Rocket Doctor Ai Inc
[{"type":"image","alt":"Rocket Doctor AI Inc.","displaySize":"","headline":null,"caption":"Rocket Doctor AI Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":51,"url":"https://media.zenfs.com/en/globenewswire.com/c58fe9f46edab2ec99ef29959709ece6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9TxOvIQs41xEIKPOqbddMw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTcxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/c58fe9f46edab2ec99ef29959709ece6","width":300,"height":51}},"lazy":false},{"type":"text","content":"Vancouver, British Columbia, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated 25th July, 2025, it has closed its non-brokered private placement of 3,677,400 special warrants of the Company (each, a “Special Warrant”) at a price of $0.50 per Special Warrant, for aggregate gross proceeds of C$1,838,700 and 4,792,000 units of the Company (each, a “Unit”) at a price of $0.50 per Unit, for aggregate gross proceeds of C$2,396,000 (the “Offering”).","length":598,"tagName":"p"},{"type":"text","content":"Dr. Essam Hamza, Chief Executive Officer of Rocket Doctor AI Inc., added: “We are appreciative of our investors for the very strong demand for this raise. These funds will help us unlock the next chapter at this critical inflection point for our company, especially enabling us to accelerate our US expansion plans. We look forward to updating the shareholders and the market as we progress.”Each Unit is comprised of one common share of the Company (each, a “Share”) and one Share purchase warrant (a "Warrant") of the Company, with each Warrant exercisable into one Share at an exercise price of $0.75 for 12 months from the date of issuance of the Warrants.","length":672,"tagName":"p"},{"type":"text","content":"Each Special Warrant will automatically convert, for no additional consideration, into one Unit on the date (the “Conversion Date”) that is the earlier of: (i) the third business day after the date of filing a prospectus supplement to a short form base shelf prospectus (the “Prospectus Supplement”) qualifying the distribution of the Shares and Warrants issuable upon the conversion of the Special Warrants, and (ii) 4 months and one day after the issue dat...